
Ruben Mesa/LinkedIn
Jun 3, 2025, 16:21
Ruben Mesa: Gene Mutations and Checkpoint Inhibitors in Head and Neck Cancer Discussed at ASCO25
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, posted on LinkedIn:
“Implications of gene mutations and checkpoint inhibitors in HN Cancer. Important work by our Atrium Health Wake Forest Baptist Comprehensive Cancer Center team presented at ASCO25 by Daniel Stamos and senior colleagues.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 16:33
Jun 4, 2025, 16:33
Jun 4, 2025, 15:56
Jun 4, 2025, 14:21
Jun 4, 2025, 13:42